Effect of the WAIO Digital Platform on Multidimensional Wellbeing in Adults in Argentina
Efecto sistémico de la Inteligencia Artificial en el Bienestar Integral en Argentina: un Modelo Multidimensional y Culturalmente Adaptado Basado en SAMHSA
This study will evaluate the effect of an artificial intelligence-supported digital wellbeing platform, Wellbeing All-In-One (WAIO), on multidimensional wellbeing in adults living in Argentina.
The study includes an initial phase to evaluate and refine a culturally adapted wellbeing questionnaire based on the eight dimensions of the SAMHSA wellness framework. It will then conduct a randomized controlled trial in which participants are assigned to either immediate access to the WAIO platform or an active waitlist control group.
Participants will be followed for six months. The study will examine changes in self-reported wellbeing across physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental dimensions, as well as engagement, retention, and safety.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
This study uses a sequential mixed-method design consisting of an instrumental calibration phase followed by a two-arm, parallel randomized controlled trial.
During the initial instrumental phase, the preliminary 40-item WAIO Integral Wellbeing Inventory, culturally adapted from the SAMHSA eight-dimension wellness framework, will undergo psychometric evaluation. The first approximately 200 participants completing the baseline assessment will contribute to this phase. The planned evaluation includes assessment of internal consistency, factorial structure, convergent validity, comprehensibility, and test-retest reliability. Items retained after this prespecified calibration process will be used for subsequent longitudinal assessments.
The experimental phase will evaluate a digital wellbeing intervention delivered through the Wellbeing All-In-One (WAIO) progressive web application. WAIO integrates more than 30 interconnected digital tools organized around eight dimensions of wellbeing: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental. Artificial intelligence is used to personalize aspects of the user experience.
A total recruitment target of 2,000 adults in Argentina is planned. Participants entering the randomized phase will be allocated to one of two parallel groups. Participants in the immediate-intervention group will receive access to WAIO and weekly engagement messages. Participants in the active waitlist control group will receive general health information monthly and will not receive access to WAIO during the six-month comparison period. Access to WAIO will be provided to the waitlist group after completion of that period.
Participants will be assessed at baseline and followed longitudinally over six months. The study is designed to evaluate the trajectory of multidimensional wellbeing, the relationship between exposure to the digital intervention and changes in wellbeing, participant retention, and intervention safety.
The study includes prespecified safety procedures for the identification and management of potentially serious risk signals detected during use of the digital platform.
Type d'étude
Inscription (Estimé)
Phase
- N'est pas applicable
Contacts et emplacements
Coordonnées de l'étude
- Nom: Leonardo M Barral, MBA
- Numéro de téléphone: +5491167992205
- E-mail: lbarral@itba.edu.ar
Lieux d'étude
-
-
Buenos Aires F.D.
-
Buenos Aires, Buenos Aires F.D., Argentine
- Instituto Tecnológico de Buenos Aires (ITBA)
-
Contact:
- Leonardo M Barral, MBA
- Numéro de téléphone: +5491167992205
- E-mail: lbarral@itba.edu.ar
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
La description
Inclusion Criteria:
- Age 18 years or older.
- Current residence in the Republic of Argentina, verified through an Argentine telephone prefix (+54).
- Demonstrated functional digital competence, defined as the ability to independently complete the digital onboarding process, including QR code scanning, two-factor identity validation, and the baseline assessment.
- Provision of digital informed consent.
Exclusion Criteria:
- Age younger than 18 years.
- Current residence outside the Republic of Argentina or inability to verify Argentine residence through the required telephone validation.
- Inability to independently complete the required digital onboarding process.
- Failure or refusal to provide digital informed consent.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Autre
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Immediate WAIO Access
Participants assigned to this arm will receive immediate access to the Wellbeing All-In-One (WAIO) progressive web application for the 6-month study period.
They will also receive one weekly WhatsApp message encouraging engagement with the platform.
WAIO integrates more than 30 interconnected digital tools organized across eight dimensions of wellbeing: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental.
|
A digital wellbeing intervention delivered through the Wellbeing All-In-One (WAIO) progressive web application.
The platform integrates more than 30 interconnected digital tools organized across eight dimensions of wellbeing: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental.
Artificial intelligence is used to personalize aspects of the user experience.
Participants assigned to the immediate-intervention arm receive access to the platform during the 6-month comparison period and one weekly WhatsApp message encouraging engagement.
|
|
Comparateur actif: Active Waitlist Control
Participants assigned to this arm will not receive access to the WAIO platform during the 6-month comparison period.
They will receive one general health information message per month through WhatsApp.
After completion of the 6-month comparison period, participants will be offered access to WAIO beginning in month 7.
|
Participants assigned to the active waitlist control arm receive one general health information message per month through WhatsApp during the 6-month comparison period.
They do not receive access to the WAIO platform during this period.
Access to WAIO is offered after completion of the 6-month comparison period, beginning in month 7.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in WAIO Integral Wellbeing Standardized Score From Baseline to 6 Months
Délai: Baseline and 6 months
|
The WAIO Integral Wellbeing Inventory assesses self-reported wellbeing across eight dimensions based on the SAMHSA wellness framework: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental wellbeing.
A standardized overall score ranging from 0 to 100 will be calculated, with higher scores indicating higher integral wellbeing.
Longitudinal scoring will use the items retained after the prespecified psychometric calibration phase.
|
Baseline and 6 months
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Change in WAIO Integral Wellbeing Standardized Score From Baseline to 3 Months
Délai: Baseline and 3 months
|
The WAIO Integral Wellbeing Inventory assesses self-reported wellbeing across eight dimensions based on the SAMHSA wellness framework: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental wellbeing.
A standardized overall score ranging from 0 to 100 will be calculated, with higher scores indicating higher integral wellbeing.
Longitudinal scoring will use the items retained after the prespecified psychometric calibration phase.
|
Baseline and 3 months
|
|
Change in the Eight Dimension-Specific WAIO Wellbeing Scores
Délai: Baseline, 3 months, and 6 months
|
Dimension-specific wellbeing scores will be calculated for the eight domains assessed by the WAIO Integral Wellbeing Inventory: physical, emotional, social, occupational, spiritual, financial, intellectual, and environmental wellbeing.
Each dimension-specific score will be standardized on a 0-to-100 scale, with higher scores indicating higher wellbeing in that dimension.
Scores will be derived from the items retained after the prespecified psychometric calibration phase.
Changes over time will be evaluated separately for each wellbeing dimension.
|
Baseline, 3 months, and 6 months
|
|
Change in Self-Rated General Health
Délai: Baseline, 3 months, and 6 months
|
Self-rated general health will be assessed using a single-item measure asking participants to rate their health in general.
Response categories are Excellent, Very Good, Good, Fair, and Poor.
Changes in the distribution of self-rated health responses will be evaluated over the follow-up period.
|
Baseline, 3 months, and 6 months
|
|
Participant Retention Rate at 3 and 6 Months
Délai: 3 months and 6 months
|
Percentage of randomized participants who remain in the study at each scheduled follow-up time point.
Retention will be assessed at T1 (3 months) and T2 (6 months) using study and platform records.
|
3 months and 6 months
|
|
Incidence of Adverse Events and Serious Adverse Events
Délai: From baseline through 6 months
|
The number and proportion of participants experiencing one or more adverse events or serious adverse events during the 6-month follow-up period will be assessed.
Safety events will be identified through the study's SOS reporting mechanism and active safety monitoring procedures.
|
From baseline through 6 months
|
|
Correlation Between WAIO Exposure and Change in Multidimensional Wellbeing
Délai: From baseline through 6 months
|
Among participants assigned to the immediate WAIO intervention arm, exposure to the digital intervention will be quantified using backend logs, including total time of use, frequency of accesses, and completion rate.
Correlation analyses will assess the relationship between these exposure indicators and the magnitude of change in overall and dimension-specific wellbeing scores from baseline to 6 months.
|
From baseline through 6 months
|
Autres mesures de résultats
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Internal Consistency of the WAIO Integral Wellbeing Inventory
Délai: Baseline
|
The scale used is the Wellbeing All-In-One (WAIO) Integral Wellbeing Inventory. Its standardized wellbeing scores range from 0 to 100, with higher scores indicating higher wellbeing. Internal consistency of the preliminary WAIO Integral Wellbeing Inventory and its dimension-specific subscales will be evaluated using Cronbach's alpha and McDonald's omega during the psychometric calibration phase. A Cronbach's alpha of 0.70 or higher is prespecified as the threshold for acceptable internal consistency of each subscale. |
Baseline
|
|
Factorial Structure of the WAIO Integral Wellbeing Inventory
Délai: Baseline
|
The scale used is the Wellbeing All-In-One (WAIO) Integral Wellbeing Inventory. Standardized wellbeing scores derived from the inventory range from 0 to 100, with higher scores indicating higher wellbeing. The factorial structure of the preliminary 40-item WAIO Integral Wellbeing Inventory will be evaluated using exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) to assess support for the hypothesized eight-dimensional wellbeing structure based on the SAMHSA framework. |
Baseline
|
|
Convergent Validity of the WAIO Integral Wellbeing Inventory
Délai: Baseline
|
The scale used is the Wellbeing All-In-One (WAIO) Integral Wellbeing Inventory. Its standardized wellbeing score ranges from 0 to 100, with higher scores indicating higher wellbeing. Convergent validity will be evaluated by examining correlations between WAIO Integral Wellbeing Inventory scores and standardized measures assessing related constructs during the psychometric calibration phase. The outcome of this analysis will be the strength and direction of the correlations between these measures. |
Baseline
|
|
Test-Retest Reliability of the WAIO Integral Wellbeing Inventory
Délai: Baseline and 14 days
|
The scale used is the Wellbeing All-In-One (WAIO) Integral Wellbeing Inventory. Its standardized wellbeing score ranges from 0 to 100, with higher scores indicating higher wellbeing. Temporal stability of the WAIO Integral Wellbeing Inventory will be assessed in a randomly selected 10% subsample of participants from the psychometric calibration phase (approximately 20 participants). The inventory will be administered again 14 days after the baseline assessment, during an intervention-free interval. Test-retest reliability will be evaluated using the intraclass correlation coefficient (ICC), with higher ICC values indicating greater temporal stability. An ICC greater than 0.75 is prespecified as the threshold for acceptable temporal stability. |
Baseline and 14 days
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Leonardo M Barral, MBA, Instituto Tecnológico de Buenos Aires
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Estimé)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- ITBA-WAIO-RCT-001
- 17771 (Autre identifiant: Ministerio de Salud, Gobierno de la Ciudad Autónoma de Buenos Aires (PRIISA.BA))
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Description du régime IPD
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .